Study S002108

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05990374
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: UNKNOWN
Enrollment: 100
Start: 2023-08-01
Primary completion: 2024-01-01
Lead sponsor: Nanjing First Hospital, Nanjing Medical University
Conditions: Diabetes
Interventions: DRUG:Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
Results posted: FALSE

Registered primary outcomes

Effects of different GLP-1 on blood glucose [1,2,3,4 year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0016638	Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus. Xu CL, Frontiers in endocrinology	2025	Randomized trial	PMID 40607222 DOI	cites ClinicalTrials.gov:NCT05990374; registry reference DERIVED:40607222